2xox: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2xox.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_2xox", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_2xox| PDB=2xox | SCENE= }} | |||
===CRYSTAL STRUCTURE OF PTERIDINE REDUCTASE (PTR1) FROM LEISHMANIA DONOVANI=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_21123874}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 21123874 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_21123874}} | |||
==About this Structure== | |||
[[2xox]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Leishmania_donovani Leishmania donovani]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XOX OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:21123874</ref><references group="xtra"/> | |||
[[Category: Leishmania donovani]] | |||
[[Category: Pteridine reductase]] | |||
[[Category: Barrack, K L.]] | |||
[[Category: Burke, L A.]] | |||
[[Category: Fyfe, P K.]] | |||
[[Category: Hunter, W N.]] | |||
[[Category: Tulloch, L B.]] | |||
Revision as of 05:09, 12 January 2011
CRYSTAL STRUCTURE OF PTERIDINE REDUCTASE (PTR1) FROM LEISHMANIA DONOVANI
Template:ABSTRACT PUBMED 21123874
About this Structure
2xox is a 2 chain structure with sequence from Leishmania donovani. Full crystallographic information is available from OCA.
Reference
- Dawson A, Tulloch LB, Barrack KL, Hunter WN. High-resolution structures of Trypanosoma brucei pteridine reductase ligand complexes inform on the placement of new molecular entities in the active site of a potential drug target. Acta Crystallogr D Biol Crystallogr. 2010 Dec;66(Pt 12):1334-40. Epub 2010, Nov 16. PMID:21123874 doi:10.1107/S0907444910040886